Camlin Fine Sciences Q1 FY27 Results: Revenue Rs 519 Cr, Net Loss Rs 35 Cr and Key Highlights
- August 12, 2026
- Posted by: Kunal Singla
- Category: News
Camlin Fine Sciences Q1 FY27: Revenue Rs 519 Cr (+22.74% YoY). Net Loss Rs 35 Cr (-202.62% YoY). Results August 11, 2026. CMP Rs 126.
Camlin Fine Sciences Q1 FY27 results were announced on August 11, 2026, reporting a net loss of Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. Revenue from operations grew 22.74% year on year to Rs 519 crore from Rs 423 crore in Q1 FY26. The Camlin Fine Sciences Q1 FY27 results are on a consolidated basis for the quarter ended June 30, 2026.
Click Here – Get Free Investment Predictions
Camlin Fine Sciences Q1 FY27 Financial Highlights
The table below summarises the key financial metrics from the Camlin Fine Sciences Q1 FY27 results compared with the same quarter of the previous year (Q1 FY26).
| Metric | Q1 FY27 (Jun 2026) | Q1 FY26 (Jun 2025) | YoY Change |
|---|---|---|---|
| Revenue from Operations (Rs Cr) | Rs 519 Cr | Rs 423 Cr | +22.74% |
| Gross Profit (Rs Cr) | Rs -9 Cr | Rs 2 Cr | -568.58% |
| Net Profit / (Loss) – PAT (Rs Cr) | Rs -35 Cr | Rs -11 Cr | -202.62% |
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends and growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks on Univest
Camlin Fine Sciences Q1 FY27 Performance Analysis
Use the Univest Screener to Track Live Fundamentals of Indian Stocks
Camlin fine sciences q1 fy27 results show revenue growth of 22.74% year on year to Rs 519 crore. Gross profit declined to Rs -9 crore from Rs 2 crore in Q1 FY26.
Net loss in the June 2026 quarter was Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. Investors tracking Camlin Fine Sciences quarterly results should verify these figures against the official BSE and NSE filings.
Key Business Factors in Camlin Fine Sciences Q1 FY27
1. Revenue Grew But Could Not Offset Losses
Revenue grew 22.74% year on year to Rs 519 crore. Despite the top-line trend, the company’s Specialty Chemicals operations remain under pressure on the profitability front.
2. Operating Costs Compressed Gross Margins
Gross profit in the June 2026 quarter stood at Rs -9 crore, reflecting elevated cost burdens relative to revenue.
3. Net Loss Persists in Q1 FY27
The company reported a net loss of Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. A return to profitability will require either a meaningful revenue ramp-up or significant cost rationalisation across Specialty Chemicals operations.
Dividend Details
No dividend has been declared alongside the Camlin Fine Sciences quarterly results for the quarter ended June 2026. Investors may track future announcements via BSE India and NSE India portals.
Camlin Fine Sciences FY27 Outlook After Q1 Results
The June 2026 quarterly performance of Camlin Fine Sciences presents a mixed picture heading into the rest of FY27. Revenue recovery and cost rationalisation will be critical for the company to strengthen its financial position. Investors tracking Camlin Fine Sciences Q1 results should monitor management guidance, sector demand in Specialty Chemicals, and any strategic moves that could alter the earnings trajectory.
Camlin Fine Sciences Stock Performance
Download the Univest iOS App or Univest Android App to track Camlin Fine Sciences live share price and upcoming quarterly results.
Camlin Fine Sciences share price stood at Rs 126 on August 11, 2026, the day the quarterly results were declared. Post-results, the market will assess whether the Specialty Chemicals company’s financial performance justifies the current valuation. Investors should verify the latest price and fundamentals on BSE and NSE before making any investment decision.
Key Risks to Watch After Camlin Fine Sciences Q1 FY27 Results
1. Sector-Specific Demand Headwinds
A slowdown in the Specialty Chemicals sector could weigh on Camlin Fine Sciences revenue and profitability beyond what the June 2026 quarter already reflects.
2. Input Cost and Margin Pressure
Rising raw material or operational costs could compress gross margins and limit net profit recovery in subsequent quarters of FY27.
3. Macroeconomic and Regulatory Uncertainty
Inflation, interest rate movements, and regulatory changes remain key risks to the earnings trajectory of Camlin Fine Sciences through FY27.
Conclusion
Camlin Fine Sciences Q1 FY27 results report revenue of Rs 519 crore and a net loss of Rs 35 crore, widening from a loss of Rs 11 crore in Q1 FY26. The June 2026 quarterly results highlight the ongoing challenges in the Specialty Chemicals space. Investors should review the full financial statements on BSE and NSE and consult a SEBI-registered advisor before any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Camlin Fine Sciences Q1 FY27 Results
When were the Camlin Fine Sciences Q1 FY27 results announced?
Ans. The June 2026 quarterly results for Camlin Fine Sciences were announced on August 11, 2026, covering the quarter ended June 30, 2026. The consolidated results were filed with BSE and NSE on the same date.
What is the PAT in the Camlin Fine Sciences Q1 FY27 results?
Ans. Net loss was Rs 35 crore in the June 2026 quarter, widening from a loss of Rs 11 crore in Q1 FY26.
What was the revenue in the Camlin Fine Sciences Q1 FY27 results?
Ans. Revenue for the June 2026 quarter rose 22.74% year on year to Rs 519 crore from Rs 423 crore in Q1 FY26.
Did Camlin Fine Sciences announce any dividend with the Q1 FY27 results?
Ans. No dividend has been declared alongside the June 2026 quarterly results. Investors may track future Camlin Fine Sciences dividend announcements through the BSE and NSE portals.
What is the Camlin Fine Sciences FY27 outlook after Q1 results?
Ans. The June 2026 quarterly performance signals a challenging start to FY27 for Camlin Fine Sciences. Key factors to watch include revenue trends, margin performance, and Specialty Chemicals sector demand through the rest of the financial year.
Is Camlin Fine Sciences a good buy after Q1 FY27 results?
Ans. The Q1 FY27 financial performance of Camlin Fine Sciences reflects challenging trends in the June 2026 quarter. This article is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered investment advisor.
